ロード中...
EXTH-47. PRECISION IMMUNOTHERAPY VACCINES FOR GLIOBLASTOMA USING CANCER IMMUNOGENOMICS AND SELECTIVE GENE ENRICHMENT STRATEGY
BACKGROUND: Development of successful immunotherapy targeting antigens in Glioblastoma (GBM) remains a challenge owing to the heterogeneous nature of GBM and the low mutation burden. It is therefore important to identify multiple tumor antigens that can be targeted simultaneously. Our goal is to dev...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7651008/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.401 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|